Skip to main content

Table 2 Association of neutrophil lymphocyte ratio with patients’ characteristics

From: Prognostic significance of neutrophil lymphocyte ratio and platelet lymphocyte ratio in advanced gastric cancer patients treated with FOLFOX chemotherapy

 

NLR < 3

NLR ≥ 3

p

 

No.

%

No.

%

 

Age

    

0.624

  < 60 years

72

66.1

37

33.9

 

  ≥ 60 years

40

61.5

25

38.5

 

Gender

    

0.136

  Male

78

68.4

36

31.6

 

  Female

34

56.7

26

43.3

 

Previous operation

    

0.002

  +

84

72.4

32

27.6

 

  -

28

48.3

30

51.7

 

Adjuvant chemotherapy

    

0.004

  +

57

77.0

17

23.0

 

  -

55

55.0

45

45.0

 

Lauren’s classification

    

0.014

  Diffuse

28

70.0

12

30.0

 

  Intestinal

21

84.0

4

16.0

 

  Mixed

51

54.3

43

45.7

 

  Unknown

12

80.0

3

20.0

 

CEA

    

1.000

  < 5 ng/ml

76

64.4

42

35.6

 

  ≥ 5 ng/ml

36

64.3

20

35.7

 

Number of metastasis

    

0.027

  1

54

56.8

41

43.2

 

  > 1

58

73.4

21

26.6

 
  1. NLR Neutrophil lymphocyte ratio, CEA Carcinoembryonic antigen.
Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us